시장조사 보고서 : 세계의 내추럴 킬러 세포 치료법 시장예측 2021년-2026년

■ 영문 제목 : Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02238 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 102 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 내추럴 킬러 세포 치료법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (NK 세포 요법, NK 세포 지향 항체)와 용도별 시장규모 (암, 위장 질환, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 내추럴 킬러 세포 치료법 시장 점유율
- 지역별 내추럴 킬러 세포 치료법 시장규모
- 주요지역의 종류별 시장규모 (NK 세포 요법, NK 세포 지향 항체)
- 주요지역의 용도별 시장규모 (암, 위장 질환, 기타)
- 미주의 내추럴 킬러 세포 치료법 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 내추럴 킬러 세포 치료법 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 내추럴 킬러 세포 치료법 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 내추럴 킬러 세포 치료법 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 내추럴 킬러 세포 치료법 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, Nkarta Therapeutics, NantKwest
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Natural Killer Cell Therapy will have significant change from previous year. By the most conservative estimates of global Natural Killer Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 201.5 million in 2020. Over the next five years the Natural Killer Cell Therapy market will register a 25.1% CAGR in terms of revenue, the global market size will reach US$ 493.6 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
NK Cell Therapies
NK Cell Directed Antibodies

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Cancer
Gastrointestinal Diseases
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Natural Killer Cell Therapy Market Size 2016-2026
2.1.2 Natural Killer Cell Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Natural Killer Cell Therapy Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Therapies
2.3 Natural Killer Cell Therapy Market Size by Type
2.3.1 Global Natural Killer Cell Therapy Market Size CAGR by Type
2.3.2 Global Natural Killer Cell Therapy Market Size Market Share by Type (2016-2021)
2.4 Natural Killer Cell Therapy Segment by Application
2.4.1 Cancer
2.4.2 Gastrointestinal Diseases
2.4.3 Others
2.5 Natural Killer Cell Therapy Market Size by Application
2.5.1 Global Natural Killer Cell Therapy Market Size CAGR by Application
2.5.2 Global Natural Killer Cell Therapy Market Size Market Share by Application (2016-2021)

3 Natural Killer Cell Therapy Market Size by Players
3.1 Natural Killer Cell Therapy Market Size Market Share by Players
3.1.1 Global Natural Killer Cell Therapy Revenue by Players (2019-2021E)
3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Natural Killer Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Natural Killer Cell Therapy by Regions
4.1 Natural Killer Cell Therapy Market Size by Regions (2016-2021)
4.2 Americas Natural Killer Cell Therapy Market Size Growth (2016-2021)
4.3 APAC Natural Killer Cell Therapy Market Size Growth (2016-2021)
4.4 Europe Natural Killer Cell Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Natural Killer Cell Therapy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Natural Killer Cell Therapy Market Size by Country (2016-2021)
5.2 Americas Natural Killer Cell Therapy Market Size by Type (2016-2021)
5.3 Americas Natural Killer Cell Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Natural Killer Cell Therapy Market Size by Region (2016-2021)
6.2 APAC Natural Killer Cell Therapy Market Size by Type (2016-2021)
6.3 APAC Natural Killer Cell Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Natural Killer Cell Therapy by Country (2016-2021)
7.2 Europe Natural Killer Cell Therapy Market Size by Type (2016-2021)
7.3 Europe Natural Killer Cell Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Natural Killer Cell Therapy by Region (2016-2021)
8.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Natural Killer Cell Therapy Market Forecast
10.1 Global Natural Killer Cell Therapy Forecast by Regions (2021-2026)
10.1.1 Global Natural Killer Cell Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Natural Killer Cell Therapy Forecast
10.1.3 APAC Natural Killer Cell Therapy Forecast
10.1.4 Europe Natural Killer Cell Therapy Forecast
10.1.5 Middle East & Africa Natural Killer Cell Therapy Forecast
10.2 Americas Natural Killer Cell Therapy Forecast by Countries (2021-2026)
10.2.1 United States Natural Killer Cell Therapy Market Forecast
10.2.2 Canada Natural Killer Cell Therapy Market Forecast
10.2.3 Mexico Natural Killer Cell Therapy Market Forecast
10.2.4 Brazil Natural Killer Cell Therapy Market Forecast
10.3 APAC Natural Killer Cell Therapy Forecast by Region (2021-2026)
10.3.1 China Natural Killer Cell Therapy Market Forecast
10.3.2 Japan Natural Killer Cell Therapy Market Forecast
10.3.3 Korea Natural Killer Cell Therapy Market Forecast
10.3.4 Southeast Asia Natural Killer Cell Therapy Market Forecast
10.3.5 India Natural Killer Cell Therapy Market Forecast
10.3.6 Australia Natural Killer Cell Therapy Market Forecast
10.4 Europe Natural Killer Cell Therapy Forecast by Country (2021-2026)
10.4.1 Germany Natural Killer Cell Therapy Market Forecast
10.4.2 France Natural Killer Cell Therapy Market Forecast
10.4.3 UK Natural Killer Cell Therapy Market Forecast
10.4.4 Italy Natural Killer Cell Therapy Market Forecast
10.4.5 Russia Natural Killer Cell Therapy Market Forecast
10.5 Middle East & Africa Natural Killer Cell Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Natural Killer Cell Therapy Market Forecast
10.5.2 South Africa Natural Killer Cell Therapy Market Forecast
10.5.3 Israel Natural Killer Cell Therapy Market Forecast
10.5.4 Turkey Natural Killer Cell Therapy Market Forecast
10.5.5 GCC Countries Natural Killer Cell Therapy Market Forecast
10.6 Global Natural Killer Cell Therapy Forecast by Type (2021-2026)
10.7 Global Natural Killer Cell Therapy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Information
11.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Offered
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Nektar Therapeutics Main Business Overview
11.1.5 Nektar Therapeutics Latest Developments
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Information
11.2.2 Innate Pharma SA Natural Killer Cell Therapy Product Offered
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Innate Pharma SA Main Business Overview
11.2.5 Innate Pharma SA Latest Developments
11.3 Affimed
11.3.1 Affimed Company Information
11.3.2 Affimed Natural Killer Cell Therapy Product Offered
11.3.3 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Affimed Main Business Overview
11.3.5 Affimed Latest Developments
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Information
11.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Chipscreen Biosciences Main Business Overview
11.4.5 Chipscreen Biosciences Latest Developments
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Information
11.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Glycostem Therapeutics Main Business Overview
11.5.5 Glycostem Therapeutics Latest Developments
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Information
11.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Offered
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Fate Therapeutics Main Business Overview
11.6.5 Fate Therapeutics Latest Developments
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Information
11.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Dragonfly Therapeutics Main Business Overview
11.7.5 Dragonfly Therapeutics Latest Developments
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Information
11.8.2 Kiadis Pharma Natural Killer Cell Therapy Product Offered
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Kiadis Pharma Main Business Overview
11.8.5 Kiadis Pharma Latest Developments
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Information
11.9.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Nkarta Therapeutics Main Business Overview
11.9.5 Nkarta Therapeutics Latest Developments
11.10 NantKwest
11.10.1 NantKwest Company Information
11.10.2 NantKwest Natural Killer Cell Therapy Product Offered
11.10.3 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 NantKwest Main Business Overview
11.10.5 NantKwest Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Natural Killer Cell Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of NK Cell Therapies
Table 3. Major Players of NK Cell Directed Antibodies
Table 4. Natural Killer Cell Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Natural Killer Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Natural Killer Cell Therapy Market Size Market Share by Type (2016-2021)
Table 7. Natural Killer Cell Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Natural Killer Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Natural Killer Cell Therapy Market Size Market Share by Application (2016-2021)
Table 10. Global Natural Killer Cell Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Natural Killer Cell Therapy Revenue Market Share by Players (2019-2021E)
Table 12. Natural Killer Cell Therapy Key Players Head office and Products Offered
Table 13. Natural Killer Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Natural Killer Cell Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Natural Killer Cell Therapy Market Size Market Share by Regions 2016-2021
Table 18. Americas Natural Killer Cell Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Natural Killer Cell Therapy Market Size Market Share by Country (2016-2021)
Table 20. Americas Natural Killer Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Natural Killer Cell Therapy Market Size Market Share by Type (2016-2021)
Table 22. Americas Natural Killer Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Natural Killer Cell Therapy Market Size Market Share by Application (2016-2021)
Table 24. APAC Natural Killer Cell Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Natural Killer Cell Therapy Market Size Market Share by Region (2016-2021)
Table 26. APAC Natural Killer Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Natural Killer Cell Therapy Market Size Market Share by Type (2016-2021)
Table 28. APAC Natural Killer Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Natural Killer Cell Therapy Market Size Market Share by Application (2016-2021)
Table 30. Europe Natural Killer Cell Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Natural Killer Cell Therapy Market Size Market Share by Country (2016-2021)
Table 32. Europe Natural Killer Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Natural Killer Cell Therapy Market Size Market Share by Type (2016-2021)
Table 34. Europe Natural Killer Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Natural Killer Cell Therapy Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Natural Killer Cell Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Natural Killer Cell Therapy
Table 43. Key Application and Potential Industries of Natural Killer Cell Therapy
Table 44. Key Challenges of Natural Killer Cell Therapy
Table 45. Key Trends of Natural Killer Cell Therapy
Table 46. Global Natural Killer Cell Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Natural Killer Cell Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Natural Killer Cell Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 52. Nektar Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 53. Nektar Therapeutics Natural Killer Cell Therapy Product Offered
Table 54. Nektar Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Nektar Therapeutics Main Business
Table 56. Nektar Therapeutics Latest Developments
Table 57. Innate Pharma SA Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 58. Innate Pharma SA Natural Killer Cell Therapy Product Offered
Table 59. Innate Pharma SA Main Business
Table 60. Innate Pharma SA Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Innate Pharma SA Latest Developments
Table 62. Affimed Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 63. Affimed Natural Killer Cell Therapy Product Offered
Table 64. Affimed Main Business
Table 65. Affimed Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Affimed Latest Developments
Table 67. Chipscreen Biosciences Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 68. Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
Table 69. Chipscreen Biosciences Main Business
Table 70. Chipscreen Biosciences Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Chipscreen Biosciences Latest Developments
Table 72. Glycostem Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 73. Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
Table 74. Glycostem Therapeutics Main Business
Table 75. Glycostem Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Glycostem Therapeutics Latest Developments
Table 77. Fate Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 78. Fate Therapeutics Natural Killer Cell Therapy Product Offered
Table 79. Fate Therapeutics Main Business
Table 80. Fate Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Fate Therapeutics Latest Developments
Table 82. Dragonfly Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 83. Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
Table 84. Dragonfly Therapeutics Main Business
Table 85. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Dragonfly Therapeutics Latest Developments
Table 87. Kiadis Pharma Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 88. Kiadis Pharma Natural Killer Cell Therapy Product Offered
Table 89. Kiadis Pharma Main Business
Table 90. Kiadis Pharma Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Kiadis Pharma Latest Developments
Table 92. Nkarta Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 93. Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
Table 94. Nkarta Therapeutics Main Business
Table 95. Nkarta Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Nkarta Therapeutics Latest Developments
Table 97. NantKwest Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 98. NantKwest Natural Killer Cell Therapy Product Offered
Table 99. NantKwest Main Business
Table 100. NantKwest Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. NantKwest Latest Developments
List of Figures
Figure 1. Natural Killer Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer Cell Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Natural Killer Cell Therapy Market Size Market Share by Type in 2020
Figure 7. Natural Killer Cell Therapy in Cancer
Figure 8. Global Natural Killer Cell Therapy Market: Cancer (2016-2021) & ($ Millions)
Figure 9. Natural Killer Cell Therapy in Gastrointestinal Diseases
Figure 10. Global Natural Killer Cell Therapy Market: Gastrointestinal Diseases (2016-2021) & ($ Millions)
Figure 11. Natural Killer Cell Therapy in Others
Figure 12. Global Natural Killer Cell Therapy Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Natural Killer Cell Therapy Market Size Market Share by Application in 2020
Figure 14. Global Natural Killer Cell Therapy Revenue Market Share by Player in 2020
Figure 15. Global Natural Killer Cell Therapy Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Natural Killer Cell Therapy Market Size 2016-2021 ($ Millions)
Figure 17. APAC Natural Killer Cell Therapy Market Size 2016-2021 ($ Millions)
Figure 18. Europe Natural Killer Cell Therapy Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Natural Killer Cell Therapy Market Size 2016-2021 ($ Millions)
Figure 20. Americas Natural Killer Cell Therapy Market Size Market Share by Country in 2020
Figure 21. Americas Natural Killer Cell Therapy Market Size Market Share by Type in 2020
Figure 22. Americas Natural Killer Cell Therapy Market Size Market Share by Application in 2020
Figure 23. United States Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Natural Killer Cell Therapy Market Size Market Share by Regions in 2020
Figure 27. APAC Natural Killer Cell Therapy Market Size Market Share by Type in 2020
Figure 28. APAC Natural Killer Cell Therapy Market Size Market Share by Application in 2020
Figure 29. China Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Natural Killer Cell Therapy Market Size Market Share by Country in 2020
Figure 36. Europe Natural Killer Cell Therapy Market Size Market Share by Type in 2020
Figure 37. Europe Natural Killer Cell Therapy Market Size Market Share by Application in 2020
Figure 38. Germany Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Application in 2020
Figure 46. Egypt Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Natural Killer Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 52. APAC Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 53. Europe Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 55. United States Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 56. Canada Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 59. China Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Japan Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 61. Korea Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 63. India Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Australia Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 65. Germany Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 66. France Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 67. UK Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Italy Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 69. Russia Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 70. Spain Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 73. Israel Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Natural Killer Cell Therapy Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 내추럴 킬러 세포 치료법 시장예측 2021년-2026년] (코드 : LPI-2201K02238) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 내추럴 킬러 세포 치료법 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 줄기 세포 치료 시장예측 2021년-2026년
LPI-2201K02308 / LP Information / 2021년 12월 / 본 조사보고서는 줄기 세포 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Stem Cell Therapy will have significant change from previous year. By the most conservative estimates of global Stem Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 387.3 million in...

세계의 종양 용해성 바이러스 치료 시장예측 2021년-2026년
LPI-2201K02250 / LP Information / 2021년 12월 / 본 조사보고서는 종양 용해성 바이러스 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Oncolytic Virus Therapy will have significant change from previous year. By the most conservative estimates of global Oncolytic Virus Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5 million in...

세계의 혈우병 유전자 치료 시장예측 2021년-2026년
LPI-2201K00120 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 유전자 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hemophilia Gene Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia Gene Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 겸상 적혈구 빈혈 치료제 시장예측 2021년-2026년
LPI-2201K02177 / LP Information / 2021년 12월 / 본 조사보고서는 겸상 적혈구 빈혈 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Sickle Cell Anemia Therapeutics will have significant change from previous year. By the most conservative estimates of global Sickle Cell Anemia Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2830.1...

세계의 플라즈마 요법 시장예측 2021년-2026년
LPI-2201K02280 / LP Information / 2021년 12월 / 본 조사보고서는 플라즈마 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Plasma Therapy will have significant change from previous year. By the most conservative estimates of global Plasma Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 239.8 million in 2020. Over...

세계의 파지 요법 시장예측 2021년-2026년
LPI-2201K02268 / LP Information / 2021년 12월 / 본 조사보고서는 파지 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Phage Therapy will have significant change from previous year. By the most conservative estimates of global Phage Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 28 million in 2020. Over...